The past few months have seen an uptick in the number of studies looking into cannabidiol’s (CBD) medical abilities. At the moment, there’s tons of anecdotal evidence in support of CBD, and users claim it’s effective against everything from insomnia and anxiety to high blood pressure and chronic pain. There have also been inroads in CBD products for pets, but the consensus is that more research is needed before cannabidiol can be Okayed.
A team of researchers in Texas is running a study to prove cannabidiol’s effects on horses, especially its anti-stress and anti-inflammatory abilities. And for animals that are often exposed to high-stress levels and strenuous physical activity, CBD could be…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.